Guillaume Bonnefois

A Probabilistic Strategy for Group-Based Dose Adaptation

F. Nekka, Jun Li, O. Barrière, 2014 .

Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure

J. Rouleau, F. Nekka, J. Tardif, 2020, Clinical and translational science.

Assembling Pharmacometric Datasets in R - The puzzle Package

F. Nekka, M. González-Sales, O. Barrière, 2020, R J..

A Computational Strategy for Dose Adaptation at the Population and Group Levels

F. Nekka, Jun Li, O. Barrière, 2015 .

An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder Treatment.

Jun Yu Li, F. Nekka, P. Robaey, 2017, Journal of child and adolescent psychopharmacology.

A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder Treatment.

F. Nekka, P. Robaey, Jun Li, 2019, Journal of child and adolescent psychopharmacology.

Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimates

N. Holford, M. González-Sales, J. Desrochers, 2021, Journal of Pharmacokinetics and Pharmacodynamics.

Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission

N. Frey, F. Mercier, N. Djebli, 2021, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations

F. Nekka, Guillaume Bonnefois, Abdullah Aljutayli, 2022, Clinical and translational science.